Skip to main content

Advertisement

SpringerLink
Log in

Tumor localization for breast cancer patients receiving neoadjuvant chemotherapy

  • Letter to the Editor
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Cha C, Lee J, Kim D, Park S, Bae SJ, Eun NL, Ahn SG, Son EJ, Jeong J (2020) Comparison of resection margin status after single or double radiopaque marker insertion for tumor localization in breast cancer patients receiving neoadjuvant chemotherapy. Breast Cancer Res Treat. https://doi.org/10.1007/s10549-020-05907-9

    Article  PubMed  Google Scholar 

  2. Early Breast Cancer Trialists' Collaborative Group (2018) Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials. Lancet Oncol 19(1):27–39. https://doi.org/10.1016/S1470-2045(17)30777-5

    Article  Google Scholar 

  3. Ko BS, Kim N, Lee JW et al (2019) MRI-based 3D-printed surgical guides for breast cancer patients who received neoadjuvant chemotherapy. Sci Rep 9(1):11991. https://doi.org/10.1038/s41598-019-46798-1

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Funding

This work was supported by a grant (2015-1327) from the Asan Institute for Life Sciences, Asan Medical Center, Seoul, Republic of Korea.

Author information

Authors and Affiliations

  1. Division of Breast Surgery, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Republic of Korea

    Zhen-Yu Wu & BeomSeok Ko

  2. Department of Breast Surgery, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China

    Zhen-Yu Wu

  3. Department of Convergence Medicine, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Republic of Korea

    Namkug Kim

Authors
  1. Zhen-Yu Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Namkug Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. BeomSeok Ko
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to BeomSeok Ko.

Ethics declarations

Conflict of interest

BeomSeok Ko and Namkug Kim hold a patent for the 3D-printed breast surgical guide and are the founding members of ANYMEDi, Inc. Zhen-Yu Wu received consulting fees from ANYMEDi, Inc.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wu, ZY., Kim, N. & Ko, B. Tumor localization for breast cancer patients receiving neoadjuvant chemotherapy. Breast Cancer Res Treat 185, 531–532 (2021). https://doi.org/10.1007/s10549-020-05950-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10549-020-05950-6

Search

Navigation